Piper Sandler maintained its Overweight rating on Five9 (NASDAQ: FIVN) but slashed the price target to $35 from $47, ...

As you can see from the chart above the percentage of shares that are sold short for Piper Sandler has grown since its last report. This does not mean that the stock is going to fall in the near ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Will Travis Kelce Play Adam Sandler's Son in Happy Gilmore 2? Actor Teases NFL Star's Role in Upcoming Sequel Adam Sandler Says His Family Is 'High Fiving' When They See Taylor Swift and Travis ...

JMP Securities analyst Devin Ryan maintained a Hold rating on Piper Sandler (PIPR – Research Report) today. The company’s shares closed yesterday at $271.44. According to TipRanks, Ryan is a ...

Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) turned lower on Wednesday after Piper Sandler downgraded the company, citing a more muted growth trajectory for Qelbree, its treatment for ...

Estée Lauder Cos. drew an upgrade to overweight from neutral at Piper Sandler on Thursday as analyst Korinne Wolfmeyer said she’s more bullish on the beauty giant after its stock has lost more ...

MINNEAPOLIS, September 09, 2024--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of Joe Kinder and Brent Blevins as managing directors to its ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Insulet (PODD – Research Report) today and set a price target of $285.00. The company’s shares closed yesterday at $233.89.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...